Daré Bioscience closes Reg A offering, issues 3,470 units at $5.00 each

Dare Bioscience, Inc.

Closed on April 10, 2026: issued 3,470 Investor Units, each at $5.00, for gross proceeds of $17,350.
Each unit contains one share of Series A Convertible Preferred Stock and two warrants to purchase 6,940 common shares total.
Offering qualified by SEC on April 1, 2026; previously disclosed in Form 8-K filed January 29, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.